We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Myhealthchecked Plc | LSE:MHC | London | Ordinary Share | GB00BN7K5L93 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -2.00% | 12.25 | 12.00 | 12.50 | 12.50 | 12.25 | 12.50 | 9,897 | 08:07:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 10.98M | -159k | -0.0031 | -39.52 | 6.5M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/9/2024 21:58 | Muck166 Agree less cash. Think Penny is a shrewd woman and probably bought a few shares at lows to bolster the book value!. Agreed the deal will be announced before results!. No share movement until news!. One thing is Penny is happy to be celebrating in August so hopefully it’s worth it for shareholders. Most have shelved the shares but that can change quickly with news | tia01 | |
11/9/2024 21:16 | Less cash, and lower revenue is my bet Tia. I’m not expecting the numbers to read great. I think they’ve been putting everything into this “exciting̶ | muck166 | |
11/9/2024 20:12 | What ever happens we will get interims by 31st. Only 3 weeks away. Penny definitely not interested in LFT tests as it’s small margins. Interesting to know if the products are in the 200 extra stores as planned yet. Interesting to know how much cash left!. | tia01 | |
11/9/2024 18:31 | News of any merger/acquisition would have to be immediately notified to the market I think, so I don’t think it’s that. Penny is clearly waiting for a third party to do something. Boots (likely). New customer (possible). Government (less likely but possible). A mix of the above (possible). The Darzi report is out tomorrow…..mig She can’t stay tight lipped for long after her teaser, and I’m sure she’d like to get news out before the interims. | muck166 | |
11/9/2024 18:02 | I seriously don’t think Penny believes there’s any money in LFT tests other than Covid ones. Fact is I’m Sure Newfoundland provide MHC with its LFT tests so I guess it’s hard for MHC to compete with them on those tests. MHC clearly focused on phlebotomy testing and I feel a deal with Boots to supply tests for NHS patients. GPs have made the government realise they need a new approach otherwise waiting lists will get even longer and waiting time also. I just feel the share price is suffering as a result of the wait for news. I don’t know what the value of Newfoundland is but could a Merger with MHC really make sense given one is focused more on LFT and the other phlebotomy tests. Time for Penny to deliver something really exciting to share so we can all go to the River Wye to celebrate lol. | tia01 | |
11/9/2024 17:47 | Dual Are they planning a merger!!!!! | tia01 | |
11/9/2024 15:48 | Interesting Newfoundland saying they have inSAIN news coming soon on LinkedIn.It may well be connected what MHC are waiting for. | dual | |
11/9/2024 15:33 | It’s beginning to feel like the board ain’t interested in anything but Boots. Shocked they never went after retailers last year. | tia01 | |
11/9/2024 09:44 | Newfoundland to launch their products in Sainsburys as well. Come MHC lets have some news. | dual | |
10/9/2024 15:45 | Muck166 I was shocked they didn’t RNS the recent deal with Newfoundland as regards the HIV tests that are labelled Newfoundland however sold via MHC. That appears to be going well but no news other than on LinkedIn regarding Newfoundland. Strange as other companies update on everything to gain attention. | tia01 | |
10/9/2024 15:25 | Honestly Tia, I have no idea. I'm not at all surprised about the continuing low volume though. The company shares very very little information to alert or excite retail investors - you only have to look at the BB's to see the lack of any investor engagement. | muck166 | |
10/9/2024 14:25 | Muck 166 What’s your take on the share movement. Surely one would expect a bit more volume given news imminent!!! | tia01 | |
10/9/2024 14:11 | Muck166 It’s definitely a strange situation in the trading. Almost like someone teasing the share away by offering slightly more for every sale!. Who knows what happens but the board need to give us something to go on!. | tia01 | |
10/9/2024 08:31 | Who knows, but I've come in here with a view that the news is material. Trading is interesting at the mo - the only real trade today has been a 50k share sale, yet the dummy bid has risen. That continues a trend I've noticed over the last week or so. | muck166 | |
10/9/2024 07:38 | Muck166 I wonder if MHC are aware that this deal is game changing and have been trying to a certain amount of shares on the cheap knowing it will create a reaction!. MHC know that the market is looking for guidance on future sales which is something MHC has been unable to provide so far as it’s in a growth mindset in relatively new sector. Any decent contract that allows a projected earnings situation will be game changing 100%. Everything comes with risks but the message put out on LinkedIn must have some substance. | tia01 | |
10/9/2024 07:10 | Muck166 I’ve believe that’s definitely possible. It’s the logical way forward to ease GP pressure. Think it’s strange why you would put a teasing post on linked in. Surely news must come soon especially as update due. | tia01 | |
10/9/2024 06:40 | Been wondering if the news Penny hinted at has anything to do with the phlebotomy services being run through Boots in support of Our Future Health/NHS. | muck166 | |
10/9/2024 06:18 | Muck166 Yeah that’s correct. Strange! | tia01 | |
10/9/2024 01:21 | It’s the Vit D rapid test that’s vanished - the Iron one is still there. | muck166 | |
09/9/2024 21:09 | hxxps://www.ndtv.com This is why we can’t knock the revenue from COVID. You never know when a new strain is coming. However we must demonstrate we can also grow revenue away from COVID to gain attention from investors. The lack of share trades is suggesting the time for news is definitely upon us. | tia01 | |
09/9/2024 20:17 | Don’t see the Iron test on boots sight! Doesn’t say coming soon either! | tia01 | |
08/9/2024 21:50 | Muck166 The buyback could be a possibility and it would only cost £520,000 to buyback 10%! If you were a CEO and watched your shares fall to all time lows and were confident in the future knowing you had the financial ability to buy at low prices you’d be smart to do so. Especially if you know a deal is coming and Penny has declared news is coming! Buying 10% stock as the resolution allowed could strengthen the books if the price rises with news. The company can release them back on to the open market if the price rises with demand. Also remember the company could effectively buyback shares with interest earned in the bank off the 8m! In the bank. That could be a smart move if they did at recent lows between 9-10p because the price is now 11.25p giving a double digit gain already which is better than a 4.75% interest received on account. | tia01 | |
08/9/2024 21:26 | We’ll find out what the news is soon enough Tia! On your points; 1. Agreed. But that growth plan needs to show some real commercial traction. 2. Agreed….but Penny can’t keep saying it. At some point there has to be traction. 3. Agree. The final results confirmed that Q1 covid revenue this year was less than Q1 last year. 4. Agreed on costs. Commercial traction is what we need to see. 5. Completely agree. If the news has anything to do with offering testing through Boots with uploads into NHS centralised digital patient records then we’re off to the races. I’ve come in here recently. I think the lack of trading update this year prior to the half year report is telling, and when you take that fact with the LinkedIn post citing a “fantasticR You will know more than me about the buyback stuff. | muck166 | |
08/9/2024 21:06 | Muck166 Also it’s clear over recent weeks whilst we haven’t really seen any great volume in MHC shares is quite noticeable the large transactions in “unknown trades”. I wonder if MHC has been buying back shares because it don’t need shareholder approval under the resolution passed last year. I believe they were allowed to buy upto 10% of the shares back however would Penny do that! Someone clearly has bought the large unknown trades because the shares have slowly increased from lows of 9p to 11.250 in the last month | tia01 | |
08/9/2024 20:56 | Muck166 hxxps://news.sky.com I think MHC has definitely been dependent on Covid revenue however we must remember that has been vital to allow us to enact a growth plan without dilution to shareholders. 2, It’s allowed us to produce products that are growing in added revenue streams however this will take a while to bed in as customers are educated on the benefits of self testing. 3, Revenue in Covid products will probably show a decline but we don’t know much stock was paid for prior to the figures due this month. 4, costs definitely associated with implementing products in over 200 news Boots branches. This will help revenue moving forward on new products. 5, If the report suggests anything regarding patients being affected by GPs cancellations etc MHC could benefit if it’s decided it’s financially beneficial to the NHS to allow more testing in Boots under a criteria that meets the requirements. Penny has alluded to this in the investor meeting and said any decision needs to be cost effective to the NHS. Is this the news Penny can’t share as yet in her linked in cryptic update!. This would be game changing for MHC if the new tests were added to pharmacy first or phlebotomy tests allowed in Boots to elevate GPs stress. MHC has invested in Digital technology heavy so you have questions why and the plans given the financial costs. My belief is they know a new government will want to demonstrate a move from GP dependance. 100% believe Penny has some big news for plans with Boots and this why she’s concentrating on a strategy with Boots. | tia01 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions